Press release
Projected Growth of 5.6% CAGR in the Pneumonia Market from 2023 to 2033 | IMARC Group
How big is the market for pneumonia?
The pneumonia market is anticipated to grow at a CAGR of 5.6% during 2023-2033.
Request for a Sample Report: https://www.imarcgroup.com/pneumonia-market/requestsample
What is pneumonia?
Pneumonia is an infectious condition that leads to inflammation and the accumulation of fluid or pus in the air sacs (alveoli) within one or both lungs. Its severity can vary, impacting individuals across all age groups, but it poses the greatest risk to older adults, infants, and people who have a compromised immune system. Some of the common symptoms of this ailment include coughing with phlegm or pus, fever, chills, difficulty breathing, chest pain, vomiting, nausea, loss of appetite, fatigue, confusion, etc. The diagnosis of pneumonia involves a combination of medical history, physical examination, and various diagnostic tests.
Explore the Full Report with Table of Contents: https://www.imarcgroup.com/pneumonia-market
What are the key drivers and trends in the pneumonia market?
The increasing cases of HIV/AIDS and cancer, which can weaken the immune system, making an individual more vulnerable to infections, are primarily driving the pneumonia market. Additionally, the growing instances of exposure to hazardous chemicals and smoking, which damage the respiratory system and impact the lung's ability to clear bacteria and other harmful substances, are also contributing to the market growth. Besides this, the escalating utilization of effective antibiotics, such as macrolides, penicillin, cephalosporins, etc., to strengthen the body's immunity and minimize symptoms associated with the ailment among patients is acting as another significant growth-inducing factor.
Furthermore, the rising adoption of chest physiotherapy techniques, including percussion, vibration, and postural drainage, that help in loosening and mobilizing mucus from the lungs is positively impacting the market growth. Additionally, the emerging popularity of nebulized medications owing to their several benefits over oral therapies, like improved drug distribution, enhanced absorption, and a quicker onset of action, is expected to fuel the pneumonia market in the coming years.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Countries Included:
United States
Germany
France
United Kingdom
Italy
Spain
Japan
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the pneumonia market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the pneumonia market
Reimbursement scenario in the market
In-market and pipeline drugs
In-Market Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=8133&flag=C
How This Report Can Help You:
The report on pneumonia market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the pneumonia market.
The pneumonia market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the pneumonia market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Browse Our Latest Healthcare Research Report:
Somatotropin Deficiency Market Report 2023-2033: https://www.imarcgroup.com/somatotropin-deficiency-market
Severe Acute Respiratory Syndrome Coronavirus Infection Market Report 2023-2033: https://www.imarcgroup.com/severe-acute-respiratory-syndrome-coronavirus-infection-market
Gastritis Market Report 2023-2033: https://www.imarcgroup.com/gastritis-market
Vulvar Cancer Market Report 2023-2033: https://www.imarcgroup.com/vulvar-cancer-market
Key Questions Answered in this Report:
How has the pneumonia market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the pneumonia market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the pneumonia market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us: -
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Projected Growth of 5.6% CAGR in the Pneumonia Market from 2023 to 2033 | IMARC Group here
News-ID: 3132330 • Views: …
More Releases from IMARC Group
Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…
Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…
Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…
Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
